Saung, M. T., & Zheng, L. (2019). Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma. Ann Pancreat Cancer.
Citação norma ChicagoSaung, May Tun, and Lei Zheng. "Adding Combination Immunotherapy Consisting of Cancer Vaccine, Anti-PD-1 and Anti-CSF1R Antibodies to Gemcitabine Improves Anti-tumor Efficacy in Murine Model of Pancreatic Ductal Adenocarcinoma." Ann Pancreat Cancer 2019.
MLA citiranjeSaung, May Tun, and Lei Zheng. "Adding Combination Immunotherapy Consisting of Cancer Vaccine, Anti-PD-1 and Anti-CSF1R Antibodies to Gemcitabine Improves Anti-tumor Efficacy in Murine Model of Pancreatic Ductal Adenocarcinoma." Ann Pancreat Cancer 2019.